If you have room in your portfolio for some new additions in November, then you might want to consider the ASX growth shares listed below.
They have recently been named as buys by experts and tipped to climb meaningfully higher from current levels. Here’s what you need to know about them:
Cochlear Limited (ASX: COH)
The first ASX growth share that has been named as a buy is Cochlear. It is one of the worldâs leading hearing solutions companies. It has been tipped to continue its growth long into the future thanks to its portfolio of world class products in an industry with high barriers of entry. Particularly given how the industry is benefiting from favourable tailwinds such as ageing populations and a growing middle class.
Goldman Sachs is bullish on Cochlear. Its analysts currently have a buy rating and $247.00 price target on its shares.
IDP Education Ltd (ASX: IEL)
Another ASX growth share that has been named as a buy is IDP Education. It is a language testing and student placement company and a co-owner of the IELTS test. This is the English test that is trusted by more governments, universities, and organisations than any other.
Goldman Sachs is a big fan of the company and is expecting strong underlying system demand to result its rapid earnings growth through to FY 2025. Goldman has a buy rating and $36.00 price target on the company’s shares.
Life360 Inc (ASX: 360)
A final ASX growth share that analysts have tipped as a buy is Life360. It is a technology company that operates in the digital consumer subscription services market, with a focus on products and services for digitally native families. The companyâs flagship product is the Life360 app, which has a whopping 40 million+ active users. It offers families features such as communications, driver safety, and location sharing.
Analysts at Bell Potter are very positive on the company. This is due to its huge total addressable market and material cross selling opportunities. Bell Potter has a buy rating and $8.25 price target on its shares.
The post Experts name 3 of the best ASX growth shares to buy in November appeared first on The Motley Fool Australia.
FREE Guide for New Investors
Despite what some people may say – we believe investing in shares doesnât have to be overwhelming or complicatedâ¦
For over a decade, weâve been helping everyday Aussies get started on their journey.
And to help even more people cut through some of the confusion âexperts” seem to want to perpetuate – weâve created a brand-new âhow toâ guide.
Yes, Claim my FREE copy!
*Returns as of November 7 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Which are the best ASX 200 shares to buy now for 2023?
- Morgans names 2 fast-growing ASX 200 shares to buy now
- ‘Very bullish’: 3 small-cap ASX shares QVG is loving right now
- 5 reasons I would avoid BrainChip shares at all costs
- Leading fund manager names the 3 ASX stocks that drove its returns higher in October
Motley Fool contributor James Mickleboro has positions in Life360, Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear Ltd., Idp Education Pty Ltd, and Life360, Inc. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/6fRHDzY
Stock Pick 